Format
Items per page
Sort by

Send to:

Choose Destination

Results: 14

Related Articles by Review for PubMed (Select 19008605)

1.

Hemoglobin E disease with concomitant tuberculosis.

Jain D, Gupta SK, Singh T.

Indian J Pathol Microbiol. 2008 Oct-Dec;51(4):570. No abstract available.

2.

[Treatment and retreatment of tuberculosis].

Vidal R, Rey R, Espinar A, de March P, Melero C, Pina JM, Sauret J.

Arch Bronconeumol. 1996 Nov;32(9):463-74. Review. Spanish. No abstract available.

PMID:
9064085
3.

Fighting tuberculosis: old drugs, new formulations.

Blasi P, Schoubben A, Giovagnoli S, Rossi C, Ricci M.

Expert Opin Drug Deliv. 2009 Sep;6(9):977-93. doi: 10.1517/17425240903130577. Review.

PMID:
19678791
4.

A philosophy of anti-infectives as a guide in the search for new drugs for tuberculosis.

Nathan C, Gold B, Lin G, Stegman M, de Carvalho LP, Vandal O, Venugopal A, Bryk R.

Tuberculosis (Edinb). 2008 Aug;88 Suppl 1:S25-33. doi: 10.1016/S1472-9792(08)70034-9. Review.

PMID:
18762150
5.

New frontiers in the therapy of tuberculosis: fighting with the global menace.

Chhabria M, Jani M, Patel S.

Mini Rev Med Chem. 2009 Apr;9(4):401-30. Review.

PMID:
19356120
6.

Pacemaker wire infection with Mycobacterium tuberculosis: a case report and literature review.

Kestler M, Reves R, Belknap R.

Int J Tuberc Lung Dis. 2009 Feb;13(2):272-4. Review.

PMID:
19146760
7.

Peptide deformylase--a promising therapeutic target for tuberculosis and antibacterial drug discovery.

Sharma A, Khuller GK, Sharma S.

Expert Opin Ther Targets. 2009 Jul;13(7):753-65. doi: 10.1517/14728220903005590. Review.

PMID:
19530983
8.

Extensively drug-resistant tuberculosis: a case report and literature review.

Ara├║jo-Filho JA, Vasconcelos-Jr AC, Sousa EM, Silveira Cd, Ribeiro E, Kipnis A, Junqueira-Kipnis AP.

Braz J Infect Dis. 2008 Oct;12(5):447-52. Review.

9.

Mycobacterium tuberculosis.

[No authors listed]

Am J Transplant. 2004 Nov;4 Suppl 10:37-41. Review. No abstract available.

10.

[Case of urinary mycobacterium fortuitum in a patient with urinary tract tuberculosis posttreatment].

Maehana T, Takahashi S, Hirobe M, Taguchi K.

Hinyokika Kiyo. 2008 Nov;54(11):741-3. Review. Japanese.

11.

Managing TB in the 21st century: existing and novel drug therapies.

Guy ES, Mallampalli A.

Ther Adv Respir Dis. 2008 Dec;2(6):401-8. doi: 10.1177/1753465808099522. Review.

PMID:
19124385
12.

A dynamic reinfection hypothesis of latent tuberculosis infection.

Cardona PJ.

Infection. 2009 Apr;37(2):80-6. doi: 10.1007/s15010-008-8087-y. Epub 2009 Mar 23. Review.

PMID:
19308318
13.

Interaction of Mycobacterium tuberculosis with the host: consequences for vaccine development.

Dietrich J, Doherty TM.

APMIS. 2009 May;117(5-6):440-57. doi: 10.1111/j.1600-0463.2009.02458.x. Review.

PMID:
19400867
14.

Multidrug-resistant to extensively drug resistant tuberculosis: what is next?

Jain A, Dixit P.

J Biosci. 2008 Nov;33(4):605-16. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk